ANI Pharmaceuticals Inc (ANIP) stock
ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3048% below fair value
$69.99−0.90 (-1.27%)
Close on Nov 17, 2026Market cap $1.61BP/E 14.9Yield –
ANI Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
ANI Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2026 was 11.1%. For fiscal 2025 it was 8.9%, against -3.0% the year before. The highest annual figure on record is 51.4% in fiscal 2014.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8.9% | +11.9 |
| FY2024 | Dec 31, 2024 | -3.0% | −6.9 |
| FY2023 | Dec 31, 2023 | 3.9% | +19.0 |
| FY2022 | Dec 31, 2022 | -15.1% | +4.6 |
| FY2021 | Dec 31, 2021 | -19.7% | −8.9 |
| FY2020 | Dec 31, 2020 | -10.8% | −13.8 |
| FY2019 | Dec 31, 2019 | 3.0% | −4.7 |
| FY2018 | Dec 31, 2018 | 7.7% | +8.3 |
| FY2017 | Dec 31, 2017 | -0.6% | −3.7 |
| FY2016 | Dec 31, 2016 | 3.1% | −17.1 |
| FY2015 | Dec 31, 2015 | 20.1% | −31.2 |
| FY2014 | Dec 31, 2014 | 51.4% | +50.4 |
| FY2013 | Dec 31, 2013 | 1.0% | +8.4 |
| FY2012 | Dec 31, 2012 | -7.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 9.3% | +5.2 |
| Q1 FY2026 | Mar 31, 2026 | 12.4% | +4.5 |
| Q4 FY2025 | Dec 31, 2025 | 11.1% | +16.5 |
| Q3 FY2025 | Sep 30, 2025 | 11.7% | +28.0 |
| Q2 FY2025 | Jun 30, 2025 | 4.0% | +5.7 |
| Q1 FY2025 | Mar 31, 2025 | 8.0% | −5.3 |
| Q4 FY2024 | Dec 31, 2024 | -5.4% | −6.3 |
| Q3 FY2024 | Sep 30, 2024 | -16.3% | −23.8 |
| Q2 FY2024 | Jun 30, 2024 | -1.7% | −7.0 |
| Q1 FY2024 | Mar 31, 2024 | 13.2% | +11.9 |
| Q4 FY2023 | Dec 31, 2023 | 0.9% | +5.4 |
| Q3 FY2023 | Sep 30, 2023 | 7.5% | +17.8 |
| Q2 FY2023 | Jun 30, 2023 | 5.4% | +25.6 |
| Q1 FY2023 | Mar 31, 2023 | 1.3% | +32.6 |
| Q4 FY2022 | Dec 31, 2022 | -4.5% | +35.1 |
| Q3 FY2022 | Sep 30, 2022 | -10.3% | −1.7 |
| Q2 FY2022 | Jun 30, 2022 | -20.2% | +8.8 |
| Q1 FY2022 | Mar 31, 2022 | -31.2% | −31.4 |
| Q4 FY2021 | Dec 31, 2021 | -39.6% | −33.3 |
| Q3 FY2021 | Sep 30, 2021 | -8.5% | −9.4 |
| Q2 FY2021 | Jun 30, 2021 | -29.0% | −3.6 |
| Q1 FY2021 | Mar 31, 2021 | 0.2% | +14.2 |
| Q4 FY2020 | Dec 31, 2020 | -6.3% | +3.7 |
| Q3 FY2020 | Sep 30, 2020 | 0.8% | −6.8 |
| Q2 FY2020 | Jun 30, 2020 | -25.5% | −37.6 |
| Q1 FY2020 | Mar 31, 2020 | -14.1% | −14.9 |
| Q4 FY2019 | Dec 31, 2019 | -10.1% | −19.6 |
| Q3 FY2019 | Sep 30, 2019 | 7.6% | −2.3 |
| Q2 FY2019 | Jun 30, 2019 | 12.1% | +6.2 |
| Q1 FY2019 | Mar 31, 2019 | 0.8% | −4.0 |
| Q4 FY2018 | Dec 31, 2018 | 9.5% | +29.9 |
| Q3 FY2018 | Sep 30, 2018 | 9.9% | +0.1 |
| Q2 FY2018 | Jun 30, 2018 | 5.9% | −0.1 |
| Q1 FY2018 | Mar 31, 2018 | 4.8% | +1.7 |
| Q4 FY2017 | Dec 31, 2017 | -20.4% | −17.5 |
| Q3 FY2017 | Sep 30, 2017 | 9.8% | +3.2 |
| Q2 FY2017 | Jun 30, 2017 | 6.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 3.1% | – |
| Q4 FY2016 | Dec 31, 2016 | -2.8% | – |
| Q3 FY2016 | Sep 30, 2016 | 6.6% | – |
See a number that looks wrong?